Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Cavan John T | Chief Financial Officer | 7 | $8.65M | $0 | 2018-07-03 |
| Lippa Arnold | Director | 3 | $8.64M | $0 | 2018-07-03 |
| BRANCACCIO JOHN P | Director | 8 | $1.73M | $0 | 2018-07-03 |
| JACOB GARY S | Director | 6 | $8.64M | $0 | 2018-07-03 |
| Foster Robert T | Chief Scientific Officer | 2 | $0 | $0 | 2018-01-03 |
| SAPIRSTEIN JAMES | Chief Executive Officer | 12 | $15.2K | $0 | 2018-01-03 |
| Sullivan-Bolyai John Z | Chief Medical Officer | 3 | $0 | $0 | 2017-07-06 |
| HOWSON TAMAR D | Director | 1 | $0 | $0 | 2017-04-10 |
| Block Timothy M. | Director | 4 | $0 | $0 | 2016-07-19 |
| Hornung William Karl | Chief Financial Officer | 2 | $0 | $0 | 2015-06-04 |
| McGuigan Christopher | Director | 2 | $0 | $0 | 2014-12-03 |
| Denoyer Bernard | Chief Financial Officer | 2 | $0 | $0 | 2014-04-03 |
| SYNERGY PHARMACEUTICALS, INC. | 10% Owner | 1 | $0 | $0 | 2014-02-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BRANCACCIO JOHN P | Director | P Buy deriv | 2018-07-03 | 2018-07-03 | 3 | $1000.00 | $3.0K | 3 | SEC↗ |
| BRANCACCIO JOHN P | Director | P Buy deriv | 2018-07-03 | 2018-07-03 | 1,725 | $1000.00 | $1.73M | 1,725 | SEC↗ |
| Lippa Arnold | Director | P Buy deriv | 2018-07-03 | 2018-07-03 | 8,625 | $1000.00 | $8.63M | 8,625 | SEC↗ |
| Lippa Arnold | Director | P Buy deriv | 2018-07-03 | 2018-07-03 | 15 | $1000.00 | $15.0K | 15 | SEC↗ |
| Cavan John T | CFO | P Buy deriv | 2018-07-03 | 2018-07-03 | 15 | $1000.00 | $15.0K | 15 | SEC↗ |
| Cavan John T | CFO | P Buy deriv | 2018-07-03 | 2018-07-03 | 8,625 | $1000.00 | $8.63M | 8,625 | SEC↗ |
| JACOB GARY S | Director | P Buy deriv | 2018-07-03 | 2018-07-03 | 15 | $1000.00 | $15.0K | 15 | SEC↗ |
| JACOB GARY S | Director | P Buy deriv | 2018-07-03 | 2018-07-03 | 8,625 | $1000.00 | $8.63M | 8,625 | SEC↗ |
| Foster Robert T | Chief Scientific Officer | A Award | 2018-01-03 | 2018-01-05 | 100,654 | — | $0 | 144,736 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award | 2018-01-03 | 2018-01-05 | 322,092 | — | $0 | 492,819 | SEC↗ |
| Cavan John T | CFO | A Award | 2018-01-03 | 2018-01-05 | 101,221 | — | $0 | 167,947 | SEC↗ |
| Cavan John T | Chief Financial Officer | A Award deriv | 2017-07-20 | 2017-07-21 | 15,000 | — | $0 | 133,688 | SEC↗ |
| Foster Robert T | Chief Scientific Officer | A Award | 2017-07-06 | 2017-07-07 | 44,082 | — | $0 | 44,082 | SEC↗ |
| Sullivan-Bolyai John Z | Chief Medical Officer | A Award | 2017-07-06 | 2017-07-07 | 58,681 | — | $0 | 58,681 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award | 2017-07-06 | 2017-07-07 | 141,061 | — | $0 | 170,727 | SEC↗ |
| Cavan John T | CFO | A Award | 2017-07-06 | 2017-07-07 | 46,726 | — | $0 | 66,726 | SEC↗ |
| Cavan John T | CFO | P Buy | 2017-06-20 | 2017-06-22 | 20,000 | $0.65 | $13.0K | 20,000 | SEC↗ |
| HOWSON TAMAR D | Director | A Award deriv | 2017-04-10 | 2017-04-11 | 35,000 | — | $0 | 80,000 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award deriv | 2017-03-06 | 2017-03-07 | 313,898 | — | $0 | 2,761,129 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award deriv | 2017-03-03 | 2017-03-07 | 313,898 | — | $0 | 2,447,231 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | M Exercise deriv | 2016-10-27 | 2016-10-31 | 16,666 | — | $0 | 2,133,334 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | M Exercise | 2016-10-27 | 2016-10-31 | 16,666 | $1.50 | $25.0K | 29,666 | SEC↗ |
| Cavan John T | Chief Financial Officer | A Award deriv | 2016-08-26 | 2016-08-29 | 18,688 | — | $0 | 118,688 | SEC↗ |
| Sullivan-Bolyai John Z | Chief Medical Officer | A Award deriv | 2016-08-26 | 2016-08-29 | 135,790 | — | $0 | 290,790 | SEC↗ |
| JACOB GARY S | Director | A Award deriv | 2016-07-19 | 2016-07-20 | 65,000 | — | $0 | 1,015,000 | SEC↗ |
| BRANCACCIO JOHN P | Director | A Award deriv | 2016-07-19 | 2016-07-20 | 65,000 | — | $0 | 200,656 | SEC↗ |
| Block Timothy M. | Director | A Award deriv | 2016-07-19 | 2016-07-20 | 65,000 | — | $0 | 169,688 | SEC↗ |
| Lippa Arnold | Director | A Award deriv | 2016-07-19 | 2016-07-20 | 32,500 | — | $0 | 77,500 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award deriv | 2016-06-13 | 2016-06-14 | 500,000 | — | $0 | 2,150,000 | SEC↗ |
| Sullivan-Bolyai John Z | Chief Medical Officer | A Award deriv | 2016-06-13 | 2016-06-14 | 20,000 | — | $0 | 155,000 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | P Buy | 2016-02-18 | 2016-02-18 | 10,000 | $1.00 | $10.0K | 13,000 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | P Buy | 2015-11-30 | 2015-12-01 | 500 | $2.15 | $1.1K | 3,000 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | P Buy | 2015-11-23 | 2015-11-24 | 2,500 | $1.64 | $4.1K | 2,500 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award deriv | 2015-06-04 | 2015-06-08 | 150,000 | — | $0 | 1,650,000 | SEC↗ |
| Hornung William Karl | Chief Financial Officer | A Award deriv | 2015-06-04 | 2015-06-08 | 15,000 | — | $0 | 165,000 | SEC↗ |
| Hornung William Karl | Chief Financial Officer | A Award deriv | 2014-12-03 | 2014-12-04 | 50,000 | — | $0 | 150,000 | SEC↗ |
| JACOB GARY S | Director | A Award deriv | 2014-12-03 | 2014-12-04 | 420,000 | — | $0 | 950,000 | SEC↗ |
| Block Timothy M. | Director | A Award deriv | 2014-12-03 | 2014-12-04 | 29,911 | — | $0 | 104,688 | SEC↗ |
| McGuigan Christopher | Director | A Award deriv | 2014-12-03 | 2014-12-04 | 118,638 | — | $0 | 415,234 | SEC↗ |
| BRANCACCIO JOHN P | Director | A Award deriv | 2014-12-03 | 2014-12-04 | 38,759 | — | $0 | 135,656 | SEC↗ |
| SAPIRSTEIN JAMES | Chief Executive Officer | A Award deriv | 2014-12-03 | 2014-12-04 | 500,000 | — | $0 | 1,500,000 | SEC↗ |
| Denoyer Bernard | Chief Financial Officer | A Award deriv | 2014-04-03 | 2014-04-04 | 20,000 | — | $0 | 40,000 | SEC↗ |
| Block Timothy M. | Director | A Award deriv | 2014-04-03 | 2014-04-04 | 15,000 | — | $0 | 74,777 | SEC↗ |
| BRANCACCIO JOHN P | Director | A Award deriv | 2014-04-03 | 2014-04-04 | 15,000 | — | $0 | 96,897 | SEC↗ |
| JACOB GARY S | Director | A Award deriv | 2014-03-19 | 2014-03-20 | 300,000 | — | $0 | 530,000 | SEC↗ |
| Block Timothy M. | Director | A Award deriv | 2014-03-12 | 2014-03-14 | 19,777 | — | $0 | 59,777 | SEC↗ |
| BRANCACCIO JOHN P | Director | A Award deriv | 2014-03-12 | 2014-03-14 | 21,897 | — | $0 | 81,897 | SEC↗ |
| McGuigan Christopher | Director | A Award deriv | 2014-03-12 | 2014-03-14 | 16,596 | — | $0 | 296,596 | SEC↗ |
| BRANCACCIO JOHN P | Director | P Buy | 2014-03-04 | 2014-03-07 | 4,393 | $1.49 | $6.5K | 6,408 | SEC↗ |
| SYNERGY PHARMACEUTICALS, INC. | 10% Owner | J Other | 2014-02-18 | 2014-02-20 | 9,000,000 | — | $0 | 0 | SEC↗ |
| BRANCACCIO JOHN P | Director | J Other | 2014-02-18 | 2014-02-20 | 2,015 | — | $0 | 2,015 | SEC↗ |
| JACOB GARY S | CEO and President | J Other | 2014-02-18 | 2014-02-20 | 32,935 | — | $0 | 32,935 | SEC↗ |
| Denoyer Bernard | Chief Financial Officer | J Other | 2014-02-18 | 2014-02-20 | 1,030 | — | $0 | 1,030 | SEC↗ |